Bone Biologics (BBLG) Enterprise Value (2016 - 2017)
Historic Enterprise Value for Bone Biologics (BBLG) over the last 2 years, with Q3 2017 value amounting to -$1.6 million.
- Bone Biologics' Enterprise Value fell 13567.29% to -$1.6 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$1.6 million, marking a year-over-year decrease of 13567.29%. This contributed to the annual value of -$620375.0 for FY2016, which is N/A changed from last year.
- Latest data reveals that Bone Biologics reported Enterprise Value of -$1.6 million as of Q3 2017, which was down 13567.29% from -$783014.0 recorded in Q2 2017.
- Over the past 5 years, Bone Biologics' Enterprise Value peaked at -$620375.0 during Q4 2016, and registered a low of -$4.2 million during Q1 2016.